Chemical Compound Review:
Tubazide pyridine-4-carbohydrazide
Synonyms:
Abdizide, Armacide, Armazide, Bacillin, Chemidon, ...
Huang,
Chern,
Su,
Wu,
Chang,
Chiang,
Chang,
Lee,
Alland,
Kramnik,
Weisbrod,
Otsubo,
Cerny,
Miller,
Jacobs,
Bloom,
Espinal,
Kim,
Suarez,
Kam,
Khomenko,
Migliori,
Baéz,
Kochi,
Dye,
Raviglione,
Sim,
Payton,
Noble,
Minchin,
Delanty,
Vaughan,
French,
Guerrero,
Cobo,
Fortún,
Navas,
Quereda,
Asensio,
Cañón,
Blazquez,
Gómez-Mampaso,
- Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. Goble, M., Iseman, M.D., Madsen, L.A., Waite, D., Ackerson, L., Horsburgh, C.R. N. Engl. J. Med. (1993)
- Isoniazid-induced carbamazepine toxicity and vice versa: a double drug interaction. Wright, J.M., Stokes, E.F., Sweeney, V.P. N. Engl. J. Med. (1982)
- A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS. Gordin, F.M., Matts, J.P., Miller, C., Brown, L.S., Hafner, R., John, S.L., Klein, M., Vaughn, A., Besch, C.L., Perez, G., Szabo, S., El-Sadr, W. N. Engl. J. Med. (1997)
- The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Zhang, Y., Heym, B., Allen, B., Young, D., Cole, S. Nature (1992)
- Treatment of Huntington's chorea with isoniazid. Perry, T.L., MacLeod, P.M., Hansen, S. N. Engl. J. Med. (1977)
- Coma from long-term overingestion of isoniazid. Salkind, A.R., Hewitt, C.C. Arch. Intern. Med. (1997)
- A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users. Chaisson, R.E., Barnes, G.L., Hackman, J., Watkinson, L., Kimbrough , L., Metha, S., Cavalcante, S., Moore, R.D. Am. J. Med. (2001)
- Isoniazid-induced obsessive compulsive neurosis. Bhatia, M.S. The Journal of clinical psychiatry. (1990)
- Halothane effect on cGMP and control of motor activity in mouse cerebellum. Triner, L., Vulliemoz, Y., Verosky, M., Alpert, M. Anesthesiology (1981)
- Molecular mechanisms of drug resistance in Mycobacterium tuberculosis. Blanchard, J.S. Annu. Rev. Biochem. (1996)
- Isoniazid and Huntington's chorea. Roccatagliata, G., Albano, C. N. Engl. J. Med. (1978)
- Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Rozwarski, D.A., Grant, G.A., Barton, D.H., Jacobs, W.R., Sacchettini, J.C. Science (1998)
- Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. Sherman, D.R., Mdluli, K., Hickey, M.J., Arain, T.M., Morris, S.L., Barry, C.E., Stover, C.K. Science (1996)
- inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K.S., Wilson, T., Collins, D., de Lisle, G., Jacobs, W.R. Science (1994)
- Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)-DNA complex. Rubin, R.L., Bell, S.A., Burlingame, R.W. J. Clin. Invest. (1992)
- Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium. Vernon, A., Burman, W., Benator, D., Khan, A., Bozeman, L. Lancet (1999)
- Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. Halsey, N.A., Coberly, J.S., Desormeaux, J., Losikoff, P., Atkinson, J., Moulton, L.H., Contave, M., Johnson, M., Davis, H., Geiter, L., Johnson, E., Huebner, R., Boulos, R., Chaisson, R.E. Lancet (1998)
- Medical causes of seizures. Delanty, N., Vaughan, C.J., French, J.A. Lancet (1998)
- Pitfalls in the care of patients with tuberculosis. Common errors and their association with the acquisition of drug resistance. Mahmoudi, A., Iseman, M.D. JAMA (1993)
- Isoniazid-rifampin fulminant hepatitis. A possible consequence of the enhancement of isoniazid hepatotoxicity by enzyme induction. Pessayre, D., Bentata, M., Degott, C., Nouel, O., Miguet, J.P., Rueff, B., Benhamou, J.P. Gastroenterology (1977)
- Nosocomial transmission of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infection. Guerrero, A., Cobo, J., Fortún, J., Navas, E., Quereda, C., Asensio, A., Cañón, J., Blazquez, J., Gómez-Mampaso, E. Lancet (1997)
- Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis. Mitchell, J.R., Zimmerman, H.J., Ishak, K.G., Thorgeirsson, U.P., Timbrell, J.A., Snodgrass, W.R., Nelson, S.D. Ann. Intern. Med. (1976)
- Isoniazid and iproniazid: activation of metabolites to toxic intermediates in man and rat. Nelson, S.D., Mitchell, J.R., Timbrell, J.A., Snodgrass, W.R., Corcoran, G.B. Science (1976)
- Isoniazid and bile duct cancer. Lowenfels, A.B., Norman, J. JAMA (1978)
- The fungicidal mechanisms of human monocytes. I. Evidence for myeloperoxidase-linked and myeloperoxidase-independent candidacidal mechanisms. Lehrer, R.I. J. Clin. Invest. (1975)
- The neurotoxicity of antibacterial agents. Snavely, S.R., Hodges, G.R. Ann. Intern. Med. (1984)
- Identification of differentially expressed mRNA in prokaryotic organisms by customized amplification libraries (DECAL): the effect of isoniazid on gene expression in Mycobacterium tuberculosis. Alland, D., Kramnik, I., Weisbrod, T.R., Otsubo, L., Cerny, R., Miller, L.P., Jacobs, W.R., Bloom, B.R. Proc. Natl. Acad. Sci. U.S.A. (1998)
- Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya. Hawken, M., Nunn, P., Gathua, S., Brindle, R., Godfrey-Faussett, P., Githui, W., Odhiambo, J., Batchelor, B., Gilks, C., Morris, J. Lancet (1993)
- Failure of ketoconazole treatment of Blastomyces dermatitidis [corrected] due to interaction of isoniazid and rifampin. Abadie-Kemmerly, S., Pankey, G.A., Dalovisio, J.R., Dalvisio, J.R. Ann. Intern. Med. (1988)
- An update on genetic, structural and functional studies of arylamine N-acetyltransferases in eucaryotes and procaryotes. Sim, E., Payton, M., Noble, M., Minchin, R. Hum. Mol. Genet. (2000)
- Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies. DiJoseph, J.F., Armellino, D.C., Boghaert, E.R., Khandke, K., Dougher, M.M., Sridharan, L., Kunz, A., Hamann, P.R., Gorovits, B., Udata, C., Moran, J.K., Popplewell, A.G., Stephens, S., Frost, P., Damle, N.K. Blood (2004)
- Elevated serum aminotransferase induced by isoniazid in relation to isoniazid acetylator phenotype. Yamamoto, T., Suou, T., Hirayama, C. Hepatology (1986)
- Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Heym, B., Honoré, N., Truffot-Pernot, C., Banerjee, A., Schurra, C., Jacobs, W.R., van Embden, J.D., Grosset, J.H., Cole, S.T. Lancet (1994)
- Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis. Huang, Y.S., Chern, H.D., Su, W.J., Wu, J.C., Chang, S.C., Chiang, C.H., Chang, F.Y., Lee, S.D. Hepatology (2003)
- Acceleration of plasminogen activation by tissue plasminogen activator on surface-bound histidine-proline-rich glycoprotein. Borza, D.B., Morgan, W.T. J. Biol. Chem. (1997)
- Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative-stress regulatory gene: implications for sensitivity to isoniazid. Deretic, V., Philipp, W., Dhandayuthapani, S., Mudd, M.H., Curcic, R., Garbe, T., Heym, B., Via, L.E., Cole, S.T. Mol. Microbiol. (1995)
- Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes. Stead, W.W., Lofgren, J.P., Warren, E., Thomas, C. N. Engl. J. Med. (1985)
- Thirty years after isoniazid. Its impact on tuberculosis in children and adolescents. Hsu, K.H. JAMA (1984)
- Toxic effects of isoniazid in tuberculosis chemoprophylaxis. Role of biochemical monitoring in 1,000 patients. Byrd, R.B., Horn, B.R., Solomon, D.A., Griggs, G.A. JAMA (1979)
- Isoniazid as preventive therapy in HIV-infected intravenous drug abusers. A decision analysis. Jordan, T.J., Lewit, E.M., Montgomery, R.L., Reichman, L.B. JAMA (1991)
- Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. Espinal, M.A., Kim, S.J., Suarez, P.G., Kam, K.M., Khomenko, A.G., Migliori, G.B., Baéz, J., Kochi, A., Dye, C., Raviglione, M.C. JAMA (2000)